We are live on ! Find out more
TI

Telemetry Investments Portfolio holdings

AUM $63.3M
1-Year Est. Return 0.06%
This Fund
S&P 500
This Quarter Est. Return
+26.17%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
AUM
$36.8M
AUM Growth
+$8.2M
Cap. Flow
+$3.54M
Cap. Flow %
9.62%
Top 10 Hldgs %
35.87%
Holding
81
New
27
Increased
10
Reduced
15
Closed
16

Sector Composition

Rank Sector Weight
1 Healthcare 27.75%
2 Financials 12.52%
3 Technology 5.99%
4 Communication Services 4.45%
5 Utilities 2.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGE
76
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
-25,500
Closed -$420K
FTSV
77
DELISTED
Forty Seven, Inc. Common Stock
FTSV
-3,000
Closed -$286K
RARX
78
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
-15,000
Closed -$720K
OMN
79
DELISTED
OMNOVA Solutions Inc.
OMN
-24,092
Closed -$244K
S
80
DELISTED
Sprint Corporation
S
-85,100
Closed -$734K
KEM
81
DELISTED
KEMET Corporation
KEM
-24,129
Closed -$583K

Similar funds

Telemetry Investments's Q2 2020 Portfolio in Review

As of Q2 2020, Telemetry Investments held 81 positions worth $36.8M, up 29% from $28.6M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Telemetry Investments deployed $3.54M of net new capital in Q2 2020, opening 27 new positions and adding to 10 existing holdings. Its largest new stake was E*Trade Financial Corporation: 34,000 shares worth $1.69M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 43% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Zosano Pharma Corporation, an estimated $2.05M trimmed.

  • Telemetry Investments's largest Q2 2020 buy was E*Trade Financial Corporation: 34,000 shares worth $1.69M.
  • Telemetry Investments added most to Bellerophon Therapeutics, Inc. in Q2 2020, an estimated $1.05M increase.
  • Telemetry Investments's biggest Q2 2020 reduction was Zosano Pharma Corporation, cutting an estimated $2.05M.
  • Telemetry Investments fully exited Allergan plc in Q2 2020, selling an estimated $3.31M.
  • Telemetry Investments's ten largest holdings make up 36% of its $36.8M portfolio in Q2 2020.
  • Telemetry Investments opened 27 new positions and closed 16 in Q2 2020.
  • Telemetry Investments's portfolio value rose 29% quarter-over-quarter to $36.8M.

Based on Telemetry Investments's 13F filing for Q2 2020, filed 14 Aug 2020.